CURRICULUM VITAE

Mohsen Janghorbani

Professor of Epidemiology

Department of Epidemiology and Biostatistics

School of Public Health

Isfahan University of Medical Sciences

Isfahan, Iran

 


Dr-Janghorbani.jpg

Personal Information

 

Family Name: Janghorbani
First Name: Mohsen
Father Name: Mostafa
Mother Name: Amin

Date of Birth: April 23, 1950

Nationality: Iranian

Marital Status: Married

Number of Children: 1 (son)

Job Title: Professor

Organisation: Isfahan University of Medical Sciences, Isfahan, Iran

Mailing Address: Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran

Telephone: (+98)311- 2334893

Fax: (+98)311-6682509
Mobile: 09113147467

E-mail: janghorbani@yahoo.com

 

 

Education

 

Institute                                    From to                  Field                          Degree

Ahwaz University, Iran            1971-1975              Radiology                  B.Sc.

Shiraz University, Iran              1975-1977              Epidemiology            MSc

Glasgow University, UK          1984-1988              Epidemiology            PhD

Karolinska Institute, Sweden   1992-1992              Advanced                  Certificate

Epidemiology and

Biostatistics

 

 

Employment

 

Institute                                             From to                Position                          Field                          Duty

Uremia University                              1977-78                Instructor                        Epidemiology           Teaching and research

Kerman University                            1978-1988            Instructor                        Epidemiology           Teaching and research

Kerman University                             1988-1992            Assistant Prof.                Epidemiology           Teaching and research

Kerman University                            1992-1999            Associate Prof.               Epidemiology           Teaching and research

Isfahan University                             1999-2000            Associate Prof.               Epidemiology           Teaching and research

Isfahan University                             2000- Now           Professor                         Epidemiology           Teaching and research

University of Hong Kong                  2000-2001            Research Fellow             Epidemiology                                     Research

University of   Plymouth, UK           2004-2005             Fellow Scientist             Epidemiology            Research

Harvard School of  Public Health     2005-2006            Visiting Scientist            Epidemiology            Research

                                                          

 

 

 


Awards

1.  Winner of the prize of best translated book, 1997 Kerman Iran .

2.  Winner of the prize of outstanding researcher, 1998, Kerman University of Medical Science, Iran.

3.  Winner of the prize of outstanding researcher, 2001, Isfahan University of Medical Science, Iran.

4.  Winner of the prize of outstanding researcher, 2002 Isfahan University of  Medical Science, Iran.

5.  Winner of the prize of outstanding researcher of Isfahan University of Medical Sciences, 2003 Isfahan, Iran.

6.  Winner of the prize of 12th Razi Feastival, 2006.

7.  Winner of the prize of outstanding researcher of Isfahan University of Medical Sciences, 2006 Isfahan, Iran.

8.  Winner of the prize of outstanding teacher of Isfahan University of Medical Sciences, 2007 Tehran, Iran.

9.  Winner of the prize of outstanding researcher of Isfahan University of Medical Sciences, 2008 Isfahan, Iran.

10. Winner of the prize of outstanding researcher of Isfahan University of Medical Sciences, 2009, Isfahan, Iran.

11. Winner of the prize of outstanding researcher of Isfahan  Province, 2009, Isfahan, Iran.

12. Winner of the prize of outstanding researcher of Isfahan University of Medical Sciences, 2010, Isfahan, Iran.

13. Winner of the prize of outstanding researcher of Isfahan University of Medical Sciences, 2011, Isfahan, Iran.

14. Winner of the prize of outstanding researcher of Isfahan University of Medical Sciences, 2012, Isfahan, Iran.

15. Winner of the prize of 18th Razi Feastival, 2012.

 

 

 

Publications

 

A: Research Publications

 

1.  Janghorbani M, Zhianpour M. An epidemiological study of tuberculosis in children under 10 years of age in Kavar area, Fars Province. Iran J Med Sciences 1980; 11:61-72.

2.  Janghorbani M. Traffic casualties in Shiraz. Iran. J Surgery 1980; 3:131-145

3.  Janghorbani M, Hedley AJ, Zhianpour M, Jones RB, Gilmur WH. Blood pressure components as predictor of ischaemic heart disease mortality in west of Scotland. Medical Journal of Islamic Republic of Iran 1991; 5:117-123.

4.  Janghorbani M, Hedley AJ, Jones RB, Gilmur WH, Gillis CR, Zhianpour M. Blood pressure components as predictor of stroke mortality in west of Scotland. Medical Journal of Islamic Republic of Iran 1990; 4:13-19.

5.  Janghorbani M, Hedley AJ,  Jones RB Gilmur WH, Zhianpour M. Trends in mortality from stroke in Scotland 1950-1986. Public Health 1992; 106: 343-350.

6.  Janghorbani M, Hedley AJ, Jones RB, Gilmur WH, Zhianpour M. Is the association between blood glucose level and “all causes” and cardiovascular mortality risk depends on body mass index. Medical Journal of Islamic Republic of  Iran 1992, 6:205-212.

7.  Janghorbani M, Hedley AJ, Jones RB, Zhianpour M, Gilmour WH. Gender differential in all cause and cardiovascular disease mortality. Int J Epidemiol 1993; 22:1056-1063.

8.  Janghorbani M, Daie-Parizi MH, Ghorbani K. Measles epidemics in Kerman, Iran. Public Health 1993; 107:79-87.

9.  Daie-Parizi MH,  Janghorbani M. Measles epidemics in Kerman. Medical Journal of Islamic Republic of Iran 1993, 604:249-254.

10. Janghorbani M, Jones RB, Hedley AJ. Using the Community Health Index, general practitioner records and the National Health Service Central Registry for a 14 year follow-up of a middle aged in the west of Scotland. Health Bulletin 1993; 51:28-33.

11. Janghorbani M,  Jones RB, Gilmour WH, Hedley AJ, Zhianpour M. A prospective population-based study of gender differential in mortality from cardiovascular disease and “all-causes” in asymptomatic hyperglycaemic. Journal of Clinical Epidemiology 1994; 47:397-405.

12. Keshavarz-Vallian H,  Janghorbani M. The efficiency of malaria screening program among Afghan refugees in Kerman, Iran. Medical Journal of Islamic Republic of Iran 1994, 8:167-171.

13. Janghorbani M, Jones RB, Hedley AJ. Is a high casual blood glucose value a predictor of later diabetes? Hamdard Medicus 1994; 37:52-57.

14. Janghorbani M, Zarkoob S. Epidemiology of primary dysmenorrhea in Kerman, Iran. Medical Journal of Islamic Republic of Iran 1994, 8:167-171.

15. Janghorbani M. Acute effect of cigarette smoking on fasting serum glucose level in non-diabetic male smokers. Hamdard Medicus 1996; XXXIX:82-86.

16. Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk of coronary heart disease among married non-smoking women. Medical Journal of  Islamic Republic of Iran 1997; 11:203-208.

17. Janghorbani M, Parvin F. Prevalence of overweight and thinness in high-school girls in Kerman, Iran. Int J Obesity 1998, 22:629-633.

18. Aali BS, Janghorbani M. Epidemiology of preeclampsia in pregnant women referred to Shahid Bahonar Hospital of Kerman, 1994. Journal of Kerman University of Medical Sciences 1997; 4:20-25.

19. Fekri AR, Janghorbani M. Late cutaneous complications in chemical warfare victims in Kerman province. Journal of Kerman University of Medical Sciences 1995; 2:108-119.

20. Sotodehnejad AR, Janghorbani M. Epidemiology of burns in Kerman: Analysis of 1000 cases. Journal of Kerman University of Medical Sciences 1995; 2:128-134.

21. Saryazdi S, Janghorbani M. Prevalence of diaper rush and influencing factors in children under 2 years of nursery schools in Kerman, 1994.  Iranian Journal of Dermatology 1997; 1:24-29.

22. Janghorbani M, Nakhai HR. Effect of passive  smoking during pregnancy on weight, length and cranial circumference at birth in Kerman, Iran. Medical Journal of Islamic Republic of Iran 1998;.12:31-36.

23. Ahmadi A, Janghorbani M. Evaluation of the growth of full-term Kermanian neonates in the first month of life. Journal of Kerman University of Medical   Sciences 1997; 4:51-60.

24. Ahmadi A, Janghorbani M. Prevalence of obesity and leanness in primary-school children in Kerman, Iran. Journal of Hamadan University of Medical Sciences 1998; 6:15-24.

25. Janghorbani M, Ahmadi A. Validity of anthropometric measurements in detection of low birth weights neonate in Kerman, Iran. Journal of the Faculty of  Medicine, Shahid Beheshti University of Medical Sciences 1999; 23:83-91.

26. Zhianpour M, Janghorbani M. How to give a paper or be a chairperson? Journal of Ghazvin University of Medical Sciences 1999; 2:65-70.

27. Janghorbani M, Hiatbakhsh M, Ebrahimi A. Long terms effects of mustard gas on pulmonary function tests in chemical warfare victims in Kerman, Iran. Journal of the Faculty of Medicine, Shahid Beheshti University of Medical Sciences 1998; 22:9-17.

28. Janghorbani M. Assessing the design, conducts, presentation and statistical content of medical studies. Journal of the Faculty of Medicine, Shahid Beheshti University of Medical Sciences 1997; 21:18-24.

29. Zhianpour M, Janghorbani M, Latif A. Ultrasonographic measurements of the normal kidney, liver, spleen, gallbladder and head of pancreas among radiology department attenders. Hamdard Medicus 1998; XLI:73-82.

30. Janghorbani M, Akhavan-Mahdavi, Masoudi HR. The relationship between ABO blood group and Rh factor with dental caries in soldiers of a military base in Kerman. Journal of Kerman University of Medical Sciences 1996;  3:87-91.

31. Janghorbani M. Effect of Islamic fasting on body weight, blood pressure, serum lipids, electrolytes, blood cell count and certain serum biochemical variables in males. Journal of Kerman University of Medical Sciences 1995; 2:183-192.

32. Janghorbani M, Zhianpour M, Tabatabaiee HR. Diagnosis and prognosis disclosure to dying adult cancer patients, part 1. physician attitude. Journal of Kerman University of Medical Sciences 1994; 1:12-17.

33. Janghorbani M, Hamzehiee-Moghadam A, Kachoiee H. Epidemiology of non-fatal stroke in Southeastern, Iran. Iranian Journal of Medical Sciences 1996; 21:135-139.

34. Janghorbani M, Farsi F. Epidemiology of pregnancies with unknown last menstrual period. Journal of Kerman University of Medical Sciences 1995; 2:61-65.

35. Foroudnia F, Janghorbani M. Characteristics of the inner city road traffic casualties in Kerman during 1994. Journal of Kerman University of Medical Sciences 1996; 3:35-42.

36. Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk of coronary heart disease among married non-smoking women. Journal of Islamic Republic of Iran 1997; 11:203-208.

37. Habibi-Khorasani AR, Janghorbani M, Darabi MR. Comparison of bronchial brushing, washing and forceps biopsies in diagnosis of bronchogenic carcinoma. Journal of Kerman University of Medical Sciences 1994; 1:58-64.

38. Janghorbani M, Nakhai HR. Effect of passive  smoking during pregnancy on weight, length  and cranial circumference at birth in Kerman, Iran. MJIRI 12:31-36; 1998.

39. Janghorbani M, Jones RB, Allison S. Incidence of and risk factors for cataract among diabetes clinic attenders. Ophthalmic Epidemiology . 2000; 7:13-25. IF 1.25

40. Janghorbani M, Shafiee-Bafti M. Effects of smoking habits of family adults on respiratory health of children in Kerman, Iran. Archive of Iranian Medicine; 1999; 2:1231-135.

41. Janghorbani M, Moazenzadeh M, Ebadzadeh MR. Relationship between age and gender, and site and type of myocardial infarction and distribution of pain. Hamdard Medicus ;2000; XLIII (2):79-87.

42. Janghorbani M, Jones RB, Allison S. Incidence of and risk factors for proliferative retinopathy and association with blindness among diabetes clinic attenders. Ophthalmic Epidemiology 2000; 7:225-41. IF 1.25

43. Janghorbani M, Jones RB, Murray KJ, Allison AP. Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmic Epidemiology; 2001; 8:309-325. IF 1.25

44. Janghorbani M. Statistical guideline for contributing to medical journals. Iranian Journal of Endocrinology and Metabolism; 2001; 3:57-70.

45. Lam TH, Janghorbani M, Fan S, Fielding R. Voluntary HIV antibody testing amongst youth in Hong Kong. International Journal of STD & AIDS 2003, 14:132-138. IF 1.51

46. Lam TH, Janghorbani M, Hedley AJ, Ho SY, McGhee SM, Chan B. Public opinion on smoking ban in restaurant and predicted effect on patronage in Hong Kong. Tobacco Control, 2002 11:195-200. IF 2.42

47. Janghorbani M, Amini M, Ghanbari H, Safaie H.. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran.. Ophthalmic Epidemiology; 2003; 10:81-95. IF 1.25

48. Janghorbani M, Ho SY, Lam TH, Janus ED. Prevalence and correlates of alcohol use: a population-based study in Hong Kong. Addiction 2003; 98:215-224 . IF 3.1

49. Janghorbani M, Lam TH. Sexual Media use by young adults in Hong Kong: Prevalence and associated factors. Archive of Sexual Behavior 2003; 32 (6):545-553. IF 2.29


50. Janghorbani M, Sadeghinia A, Asilian A, Mohammadzadeh Z.Primary results of topical dairy extract (MJ1) versus intralesionally-administered meglumine anitmonate for treatment of cutaneous leishmaniasis in Isfahan, Iran: a randomized controlled clinical trial. Hamdard Medicus 2003; XLVI: 53-58..

51. Zhianpour M, Janghorbani M. Effect of clinical information on  brain CT scan interpretation: a blinded double crossover study. Medical Journal of Islamic Republic of Iran; 2003; 13(3):173-177.

52. Habibi-Khorasani, Janghorbani M, Gozashti H, Samareh-Fekri M. Prevalence of asthma in elementary school children in Kerman in 1999. Journal of Kerman University of Medical Sciences. 2002; 9:184-193.

53. Janghorbani M (editorials). Epidemiology of sever acute respiratory syndrome (SARS). Journal of Research in Medical Sciences. 2003, 8: 1-7.

54. Janghorbani M. Commentary: Assessment of rapid clinical response in acute manic patients treating with oral loading sodium valproate. Journal of Research in Medical Sciences. 2003, 8: 30-1.

55. Janghorbani M. Commentary: Where is cut-off point between volume of  euthyroid and enlarged thyroid? Journal of Research in Medical Sciences. 2003, 8: 73-74.

56. Janghorbani M, Ho SY, Lam TH, Janus ED. Association between total and beverage-specific alcohol intake and obesity and fat distribution.: a populationbased study in Hong Kong. Alcohol Research 2003; 8(6):263-270.

57. Janghorbani M, Garak-Yaraghi M, Sherkat R, Izadi S, Rafiee-Moghadam B. Anti-cardiolipin antibodies and risk of coronary heart disease. Hamdard Medicus, 2005; XLVIII:107-111.

58. Aminoroaya A,  Janghorbani M,  Ramezani M,  Haghighi S, Amini M. Does bromocriptine improve glycemic control of obese type 2 diabetes? Hormone Research. 2004; 62:55-59.

59. Janghorbani M, Amini M.Cataract in type 2 diabetes in Isfahan, Iran: Incidence and risk factors. Ophthalmic Epidemiology; 2004; 11 (5): 347-358. IF 1.25

60. Janghorbani M, Taghdisi MT, Vingard E . Public opinion on smoking ban in restaurant  in Isfahan, Iran. Archive of Iranian Medicine, 2004; 7:260-266.

61. Aminoroaya A,  Janghorbani M,   Amini M. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus. Nephron Clinical Practice. 2005; 99:73-77.

62. Janghorbani M, Stenhouse E, Jones RB, Millward A. Is neighbourhood deprivation a risk factor for gestational diabetes mellitus? Diabetic Medicine 2006; 23:313-317. IF 2.73

63. Janghorbani M, Sharifirad GR. Completed and attempted suicide in Ilam, Iran (1995-2002): Incidence and associated factors. Archive of Iranian Medicine, 2005; 8:119-126.

64. Janghorbani M, Stenhouse E, Jones RB, Millward A. Gestational diabetes mellitus in Plymouth, UK: prevalence, seasonal variation and associated factors. The Journal of Reproductive Medicine 2006; 51:128-134.

65. Janghorbani M, Amini M. Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta Cardiologica; 2006; 61:13-20.If 0.64

66. Cooper S, Janghorbani M, Cooper G. A decade of in-hospital resuscitation: Outcomes and prediction of survival? Resuscitation 2006; 68:231-237. IF 1.76

67. Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors. Diabetes Research and Clinical Practice 2005; 70:71-80. IF 1.24

68. Janghorbani M, Stenhouse E, Millward A, Jones RB. Neighborhood deprivation and preterm birth in Plymouth, UK. The Journal of Maternal-Fetal and Neonatal Medicine; 2006; 19:85-91.

69. Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Comparison of the effect of topiramate and sodium valporate in migraine prevention. Headache 2005; 46:642-648. IF 2.46

70. Ashtary F, Janghorbani M, Chitsaz A, Reisi M, Bahrami A. A randomizes double blind trial of bromocriptine efficacy in non—fluent aphasia after stroke. Neurolgy 2006; 66:914-6. IF 5.21

71. Etemadifar M, Janghorbani M, Shaygannejad V. Comparison of betaferon, avonex and rebif in treatment of relapsing-remitting multiple sclerosis. Acta Neurologica Scandinavica 2006; 113:283.

72. Janghorbani M, Feskanich D, Willett WC, Hu F. Prospective study of diabetes mellitus and risk of hip fracture: The Nurses Health Study. Diabetes Care 2006; 29:1573-8. IF 7.07  

73. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtary F. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27:39-44. IF 1.39

74. Janghorbani M, Rezvanian  H, Kachooei  A, Ghorbani A, Chitsaz  A, Izadi, F, Amini M. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors. Acta Neurologica Scandinavica 2006; 14:384-91.

75. Janghorbani M. Impact factor: What is impact factor. Resaech in Medicine 2005; 29:117-121.

76. Janghorbani M, Jones RB, Nelder R. Neighborhood deprivation and excess coronary heart disease mortality and hospital admissions in Plymouth, UK: an ecological study. Acta Cardiologica; 2006; 61:313-320.

77. Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G, Rexrode KM. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: The Nurses' Health Study.Diabetes Care. 2007 ; 30:1730-35.

78. Janghorbani M, Amini M, Willett WC, Gouya MM,  Delavari AR, Alikhani S, Mahdavi AR. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity (Silver Spring) 2007; 15 (11):2797-808.

79. Janghorbani M, Zare M, Saadatnia M, Mousavi SA, Mojarrad M, Asgari E. Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurologica Scandinavica 2008; 117 (2): 117-121.

80. Etemadifar M, Janghorbani M,  Shaygannejad V. Comparison of interferon beta products and azathioprine in the treatment of relapsing -remitting multiple sclerosis. Journal of Neurology 2007; 254(12):1723-8.

81. Safaei H,  Janghorbani M, Aminorroaya A, Amini M. Lavastatin effects on bone mineral density in post menopausal women with type 2 diabetes mellitus. Acta Diabetologica 2007; 44:76-82.

82. Janghorbani M, Van Dam R, Willett WC, Hu F. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007; 166(5):495-505.

83. Janghorbani M, Amini M, Gouya MM,  Delavari AR, Alikhani S, Mahdavi AR. Association  of body mass index and abdominal adiposity with educational level in Iranian adults. Obesity and Metabolism-Milan 2007; 3:183-190.

84. Janghorbani M,  Rexrode KM, Logroscino G. Letter to the Editor -  Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Response to Tuttolomondo et al. Diabetes Care 2007; 30:2115.

85. Janghorbani M, Amini M. Metabolic syndrome in type 2 diabetes mellitus in Isfahan, Iran: prevalence  and risk factors. Metabolic Syndrome and Related            Disorders; 2007; 5 (3): 243-254.

86.  Janghorbani M, Amini M, Gouya MM,  Delavari AR, Alikhani S, Mahdavi AR. Nationwide survey of prevalence and risk factors of prehypertension  and hypertension in Iranian adults. Journal of Hypertension 2008;   26:419- 426.

87.  Safaei H, Amini M, Janghorbani M. The effect of HMG-CoA Reductase inhibitor (Lovastatin) on bone mineral density (BMD) in postmenopausal women with type 2 diabetes. Iranian Journal of Endocrinology & Metabolism 1384; 26(7): 142-135.

88.  Motamedi B, Janghorbani M, Eftekhari. Prevalence of cesarean section and some determinant factors in Kerman. Journal of  Medical Faculty Guilan University of Medical  Sciences 1379;34-33(9): 95-88.

89. Zhianpour M, Janghorbani M. Diagnostic accuracy of chest X-ray and appearance of bronchogenic carcinoma. Journal of  Medical Faculty Guilan University of Medical Sciences. 1378;30-29(8): 27-21.

90. Amini M, Janghorbani M. Diabetes and impaired glucose regulation in first degree relatives of patients with type 2 diabetes in Isfahan, Iran: Prevalence and risk factors. The Review of Diabetes Studies; 2007; 4:169.76.

91. Janghorbani M, Pourabdian S. ABO Blood Group and Risk of Overweight, Underweight, and Obesity. Obesity and Metabolism- Milan; 2007; 4:106-109.

92. Janghorbani M, Nakhai-Pour HR. Evidence on beneficial effects of statins on osteoporosis in diabetic women inconclusive. Review of Endocrinology March 2008; 9:26-29.

93. Adibi A, Janghorbani M, Shayganfar S, Amini M. First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease. Rev Diabet Stud. 2007; 4(4):236-41.

94. Janghorbani M, Amini M, Gouya MM,  Delavari AR, Alikhani S, Mahdavi AR. Gender Differential in the Association of Body Mass Index and Abdominal Obesity with Prehypertension and Hypertension in Iranian Adults. Obesity  and Metabolism- Milan 2008; 4:169-176.

95. Shaygannejad V, Janghorbani M, Ashtari F, Afsharznjzni H, Zakizade N. Effects of rivastigmine on memory and cognition in multiple sclerosis. Canadian Journal of Neurological Sciences 2008; 35:476-481.

96. Siavash  M, Janghorbani M, Gheshlaghi F, Adeli SH, Saljoughi M, Moradi F, Majidinezhad M. A Case Series of Abuse of a New Opioid Combination, Norjizak. Journal of Addictive Diseases 2009; 28:180-185.

97. Chitsaz A, Janghorbani M, Shaygannejad V, Ashtari F, Heshmatipour M, Freeman F. Sensory  complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous nerve stimulation. The Clinical Journal of Pain 2009; 25:281-285.

98. Janghorbani M, Sheikhi Mehrabadi A, Pourabdian S. The prevalence and correlate of hearing loss in drivers in Isfahan, Iran. Archive of Iranian Medicine 2009, 12(2): 128-34.

99. Janghorbani M, Amini M. Pattern and predictors of long-term weight change in patients with type 2 diabetes mellitus. Annals of Nutrition and Metabolism 2009; 54 (2):111-118.

100.  Amini M, Janghorbani M. Comparison of Metabolic Syndrome with Glucose Measurement for Prediction of Type 2 Diabetes: the Isfahan Diabetes Prevention Study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews; 2009, 3:84-89.

101.  Aminorroaya, A, Janghorbani, M, Amini M, Hovsepian S, Tabatabaei A, Fallah Z. Prevalence of Thyroid Dysfunction in an Iodine-Sufficient Area in Iran. Archive of Iranian Medicine 2009; 12:262-70.

102. Amini M, Janghorbani M. A risk score for prediction of type 2 diabetes: the Isfahan Diabetes Prevention Study. Obesity and Metabolism 2009; 5: 13-19.

103.  Izadi M, salehi H, chinikar S, Mostafavizadeh K, Darvishi M, Jonaidi N, Ranjbar R, Khorvash F, Bidar R, Ataee B, Heidari M, Janghorbani M. A Geographical Distribution Survey on CCHF Positive Antibody Bovine's of  Isfahan Province in 1383-1384. Journal of Military Medicine 2007; 2(9): 97-102.
104.  Janghorbani M, Amini M. Diabetes Risk Among First-Degree Relatives of Patients with Type 2 Diabetes in Isfahan, Iran. Obesity and Metabolism 2009; 5:114-120.

105.  Janghorbani M, Amini M. Comparison of Fasting Glucose with Post-Load Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study. The Review of Diabetic Studies 2009; 6:117-123.

106.  Janghorbani M, Amini M, Rezvanian H, Gouya MM,  Delavari AR, Alikhani S, Mahdavi AR. ASSOCIATION OF BODY MASS INDEX AND ABDOMINAL OBESITY WITH MARITAL STATUS IN IRANIAN ADULTS. Arch Iran Med. 2008;11:274-81.

107.  Danesh A, Janghorbani M, Mohammadi B. Effects of zinc supplementation during pregnancy on pregnancy outcome in women with history of preterm delivery. A double-blind randomized, placebo-controlled trial. J Matern Fatal Neonatal Med. 2010; 23 (5):403-408.

108.  Janghorbani M, Amini M. Progression to impaired glucose metabolism in first degree relatives of patients with type 2 diabetes in Isfahan, Iran. Diabetes/Metabolism Research and Reviews 2009; 25:748-755.
109.
 Janghorbani M, Amini M. Normalization of Glucose Intolerance in First-Degree Relatives of Patients with Type 2 Diabetes. Diabetes Research and Clinical Practice 2010, 88(3):295-301.

110.  Shaygannejad V,  Janghorbani M, Savoj MR, Ashtari F. Effects of adjunct glucosamine sulfate on relapsing-remitting multiple sclerosis progression: Preliminary findings of a randomized, placebo-controlled trial. Neurological Research 2010; 32(9):981-5.

111.  Janghorbani M, Amini M. Comparison of Body Mass Index with Abdominal Obesity Indicators and Waist-to-Stature Ratio for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study. Obesity Research & Clinical  Practice 2010; 4:e25-e32.

112.  Janghorbani M, Amini M. Predictors of switching to insulin from non-insulin therapy in patients with type 2 diabetes. Journal of Diabetes research and Clinical Practice 2011; 92:111-117.

113.  Pourabdian   S,   Janghorbani   M,   Khoubei   J,  Tajvidi  M,  Mohebbi  I. Relationship between high risk occupation particularly aromatic amines exposure and bladder cancer in Isfahan: a case-control study. The Journal of Urmia       University of Medical Sciences 2010; 21 (2):124-134.

114.  Janghorbani M, Amini M. Comparison of Systolic and Diastolic Blood Pressure with Pulse Pressure and Mean Arterial Pressure for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study. Endokrynologia Polska 2011; 62:324-30.

115.  Janghorbani M, Enjezam B. Review of epidemiology of gestational diabetes in Iran. Journal of Isfahan Medical School 2010; 28:225-240.

116.  Janghorbani M, Amini M. Incidence of Type 2 Diabetes by HbA1c and OGTT: The Isfahan Diabetes Prevention Study. Acta Diabetologica 2010: in press.
117.  Janghorbani M, Amini M, Salehi-Marzijarani M. Weight Change,  Blood Pressure, Lipids and Glycemic Control among Patients with Type 2 Diabetes. Annals of Nutrition and Metabolism 2011; 58:141-149.

118.  Karami M, Janghorbani M, Dehghani AR, Riahinejad M. Orbital Doppler Evaluation of Blood Flow Velocities in Optic Neuritis. Korean Journal of Ophthalmology 2011; in press.

119.  Karami M, Janghorbani M, Dehghani AR, Riahinejad M. Orbital Doppler Evaluation of Blood Flow Velocities in Optic Neuritis. Iranian Journal of Ophthalmology 2011; 23:11-18.

120.  Daraei  A, Salehi R, Salehi M, Emami MH, Jonghorbani  M, Mohamadhashem F, Tavakoli H. Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population. Med Oncol. 2011 May 13. [Epub ahead of print].

121.  Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980:   systematic   analysis   of   health   examination   surveys   and epidemiological studies with 960 country-years and 9·1 million  participants. Lancet. 2011; 377(9765):557-67.

122.  Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol).
     
National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years  and 3·0  million  participants.  Lancet.      2011; 377(9765):578-86.

123.  Khalili GR,  M, Sajedi P, Ahmadi GH. Effects of Adjunct Intrathecal  Magnesium  Sulfate  to  Bupivacaine  for  Spinal  Anesthesia:  A Randomized,  Double-Blind  Trial  in  Patients  Undergoing  Lower  Extremity Surgery. Journal of Anesthesia 211; 25:892-897.

124.  Janghorbani M, Amini M. Associations of Hip Circumference and Height with Incidence of Type 2 Diabetes: The Isfahan Diabetes Prevention Study. Acta Diabetologica 2011 (in  press).

125.  Karami Nogourani M, Janghorbani M, Kowsari Isfahan R, Hosseini Beheshti M. Effects of Chewing Different Flavored Gums on Salivary Flow Rate and pH. International Journal of Dentistry 2012; 2012:569327.

126.  Janghorbani M, Amini M. Incidence of metabolic syndrome and its risk factors  among  type 2  diabetes  clinic  attenders  in  Isfahan,  Iran.  ISRN Endocrinology 2012:167318.

127.  Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes  2012; 36:1485-1493.

128.  Janghorbani M, Amini M. Metabolic syndrome in first degree relatives of patients with type 2 diabetes: incidence and risk factors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2011; 5:201-206.

129.  Shaygannejad V, Janghorbani M, Ashtari F, Dehghan H. Effects of adjunct low-dose  vitamin  D  on  relapsing-remitting  multiple  sclerosis  progression: Preliminary  findings  of  a  randomized,  placebo-controlled  trial.  Multiple Sclerosis International 2012 2012:452541.

130.  Janghorbani M, Amini M. Normal Fasting Plasma Glucose and Risk of Pre-diabetes and Type 2 Diabetes: The Isfahan Diabetes Prevention Study. Review of Diabetic Studies 2012; 8:490-498.

131.  Mohammad   Hassan   Emami,   Soheila   Kouhestani,   Somayeh   Karimi, Abdolmahdi   Baghaei,   Mohsen   Janghorbani,   Nahid   Jamali,   and   Ali Gholamrezae. Frequency of Celiac Disease in Adult Patients with Typical or  Atypical Malabsorption Symptoms in Isfahan, Iran. Gastroenterology Research and Practice 2012, Article ID 106965, 6 Pages

        132.  Janghorbani M, Dehghani M, Salehi-Marzijarani M. Systematic review and meta-analysis of insulin therapy and risk of cancer. Hormones and Cancer 212; 3:137-146.

133.  Azizi  F,  Ghanbarian  A, Momenan  AA, Hadaegh  F, Mirmiran  P, Hedayati M , Mehrabi Y, Zahedi-Asl S, Ainy S, Allahverdian S, Amirshekari G, Arshadi A, Askari   S, Atifeh   M, Azimzadeh   I, Azizi   T, Daneshpour   M,  Emami H, Eskandari  F, Fakhimi  T, Ghanbili  MJ, Gahazi  AA, Habibian  S, Hajibabai M, Hajiour R, Harati H, Heydarian P, Hosseini F, Hosseinpanah F, Janghorbani M, Kalhor  Y, Majid  M, Malekafzai  H, Mehrabani  H, Mirhosseii  M, Moeini AS, Mojarad M, Nemati K, Noori A, Padyab M, Rahmani M, Saadat N, Saadati N, Sadegholvad   M, Sarbazi   N, SarrafZadeh   A, Shafiei   N, Shiva   N, Tohidi M, Zabetian A. Prevention of non-communicable disease in a  population in     nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009; 10: art. No. 5.

134.  Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H. Comparison of the effect of aspirin and amantadin for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. Neurological Research 212 (in press). 

135.  Nogourani MK, Janghorbani M, Khadem P, Jadidi Z, Jalali S. A 12-month clinical evaluation of pit-and-fissure sealants placed with and without etch-and-rinse and self-etch adhesive systems in newly-erupted teeth. J Appl Oral Sci. 2012 Jun; 20(3):352-6.

136.  Janghorbani M, Momeni F, Dehghani M. Hip circumference, height and risk of type 2 diabetes: systematic review and meta-analysis. Obesity Reviews 212; 13:1172-81.

137.  Janghorbani M, Amini M. Patterns and Predictors of Long-Term Glycemic Control in Patients with Type 2 Diabetes. ISRN Endocrinology  2012; 2012:526824. doi: 10.5402/2012/526824. Epub 2012 Oct 16.

138.  Danesh A, Janghorbani M, Khalatbari S. Effects of Antenatal Corticosteroids on Maternal Serum Indicators of Infection in Women at Risk for Preterm Delivery: A Randomized Trial Comparing Betamethasone and Dexamethasone. Journal of Research in Medical Sciences 2012; 7: 911-917.

139.  Janghorbani M, Amini M. Glycated hemoglobin as a predictor for metabolic syndrome in an Iranian population with normal glucose tolerance.  Metabolic Syndrome and Related Disorders 2012; 10:430-36.

140.  Khalili  GR,  Jonghorbani  M,  Saryazdi  H,  Emaminejad  A.  Effect  of  preemptive  and  preventive  acetaminophen  on  postoperative  pain  score:  a randomized, double-blind trial in patients undergoing lower extremity surgery. Journal of Clinical Anesthesia 2013; 25 (30:188-192.

141.  Janghorbani M, Amini M. Comparison of glycated hemoglobin with fasting plasma glucose in definition of glycemic component of the metabolic syndrome in an Iranian population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2012; 6:136-9.

142.  Janghorbani M, Amini M. Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran. Endokrynol Pol. 2012; 63(5):372-80.

143.  Karami M, Janghorbani M, Dehghani AR, Khaksar K, Kaviani A. Orbital Doppler Evaluation of Blood Flow Velocities in Patients with Diabetic Retinopathy. Review of Diabetic Studies 212; 9: 104-111.
144.
 Shaygannejad V,  Janghorbani M, Vaezi A, Haghighi S, Golabchi K, Heshmatipour M. Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.  Neurological Research 2013 in press.

145.  Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, Bahalim AN, McIntire RK, Gutierrez HR, Cowan M, Paciorek CJ, Farzadfar F, Riley L, Ezzati M for the Global Burden of Metabolic Risk Factors of Chronic Diseases. Collaborating Group (Body Mass Index). National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012; 10(1):22.

146. Janghorbani M, Piraei E. Association between air pollution and preterm birth among neonates born in Isfahan, Iran. Journal of Research in Medical Sciences 2013; 18:875-881.

147. Keykha M, Janghorbani M, Amini M. Prevalence and Risk Factors of Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of Patients with Type II Diabetes. Journal of Kerman University of Medical Sciences 2013; 20:115-128.

148.  Salamat  MR,  Salamat  AH,  Abedi  I,  Janghorbani  M.  Relationship between weight, body mass index and bone mineral density in men referred for dual-energy X-ray absorptiometry scan in Isfahan, Iran. Journal of Osteoporosis 2013; 2013:205963.

149.  Shahmansouri, Janghorbani M, Salehi Omran A, Karimi AA, Noorbala AA,  S. Effects of a psychoeducation intervention on fear andُArjmandi A, Nikfam anxiety about surgery: Randomized trial in patients undergoing coronary artery bypass grafting. Psychology Health and Medicine; 2014; 19 (4):375-83.
150
. Janghorbani M, Abbasi A. Comparison of Pregnancy Outcomes of Low Molecular Weight Heparin with Unfractionated Heparin in the Treatment of Recurrent Abortion Secondary to Antiphospholipid Syndrome. J Babol Univ Med Sci 213; 15:17-23.

151.  Janghorbani M, Adineh HA, Amini M. Finnish Diabetes Risk Score to Predict Type 2 Diabetes: the Isfahan Diabetes Prevention Study. Diabetes Research and Clinical Practice 2013; 102:202-209.

152.  Janghorbani M, Mansourian M, Hosseini E. Systematic review and meta-analysis of age at menarche and risk of type 2 diabetes. Acta Diabetologica 2014 (in press).

153.  Farnam F, Janghorbani M, Merghati E. Vaginismus and its correlates in an Iranian clinical sample. International Journal of Impotence Medicine: The Journal of Sexual Medicine 2014; in press.

154.  Salari M, Janghorbani M, Etemadifar M, Dehghani AR, Razmjoo H, Naderian GA. Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial. Journal of Research in Medical Sciences 2014 in press.

         155.  Janghorbani M, Momeni F, Mansourian M. Systematic review and meta-analysis of air pollution exposure and risk of diabetes.  

          European Journal of Epidemiology 2014 (in press).

156.  Janghorbani M, Amini M. Low-density lipoprotein cholesterol and metabolic syndrome in an Iranian high-risk population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2014, in press.

157.  Vakili B, Rahimi H, Ataei B, Janghorbani M, Khorvash F, Shoaei P, Yaran M. Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study. J Res Med Sci. 2014 Mar;19 (Suppl 1):S9-S12.

158.  Farnam F, Janghorbani M, Merghati-Khoei E, Raisi F. Compare the effectiveness of PLISSIT and Sexual Health Models on women’s sexual problems in Tehran, Iran: a randomized controlled trial. Journal of Sexual  Medicine.  2014, in press

 

 

Presentations

 

1. Janghorbani M, Jones RB, Allison S. Incidence of and risk factors for cataract  among  diabetes  clinic  attenders. 7th  Iranian  Congress  of Ophthalmology 14-17 March 1998, Isfahan, Iran.

2. Janghorbani M, Jones RB, Allison S. Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders. 7th Iranian Congress of Ophthalmology 14-17 March 1998, Isfahan, Iran

3. Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk of coronary heart disease among married non-smoking women. The first eastern Mediterranean Congress on Preventive Cardiology and 10th Annual  Iranian Congress of cardiovascular disease May 2-5, 1997, Isfahan, Iran.

4. Janghorbani  M,  Moazenzadeh  M,  Ebadzadeh  MR.  Relationship between age and gender, and site and type of myocardial infarction and distribution of pain. 3rd International Heart Health Conference 29 August - 2 September 1998 Singapore.

5. Janghorbani M, Parvin F. Prevalence of overweight and thinness in high-school girls in Kerman, Iran. IV International Epidemiological association   Eastern   Mediterranean   Regional   Scientific   Meeting November 18-21, 1998, Tunis Tunisia.

6. Janghorbani M, Ahmadi A. Validity of anthropometric measurements in detection of low birth weights neonate in Kerman, Iran. Emirates International Congress on Perinatology November 11-13, 1998 Abu Dhabi, United  Arab Emirates.


7. Janghorbani  M,  Nakhai  HR.  Effect  of  passive    smoking  during pregnancy on birth weight, length at birth and cranial circumference in Kerman, Iran. 3rd IEA/EMR Scientific Meeting October 22-25, 1997, Beirut Lebanon.

8. Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk of coronary heart disease among married non-smoking women. 10th Word Conference on Tobacco or Health 24-28 August 1997, Beijing China.

9. Janghorbani  M,  Nakhai  HR.  Effect  of  passive    smoking  during pregnancy on birth weight, length at birth and cranial circumference in Kerman, Iran. 10th World Conference on Tobacco or Health 24-28 August 1997, Beijing China.

10.Janghorbani M, Sadeghi-Golmakani N. Passive smoking and the risk of coronary heart disease among married non-smoking women. 4th International Conference on Preventive Cardiology June 29- July 3 1997 Montreal  Canada.

11.Janghorbani M, Jones RB. Incidence of and risk indicators for diabetic retinopathy in diabetic clinic attenders. XIV International Scientific meeting of the International Epidemiological Association August 27-30 1996, Nagoya Japan.

12.Hyatbakhsh M, Janghorbani M, Hajipour S. Relationship between serum alaninaminotransferase and diabetes mellitus. From Science to Practice   Congress:  20   universally   of   Medical   School,   Kerman University of  Medical  Sciences,  October 31-November 2, 1998, Kerman, Iran.

13.Janghorbani M, Shafiee-Bafti M. Effects of smoking habits of family adults on respiratory health of children in Kerman, Iran. From Science to  Practice  Congress: 20  universally  of  Medical  School,  Kerman University  of  Medical  Sciences,  October 31-November 2, 1998, Kerman, Iran.

14. Pourseidi  B,  Janghorbani  M,  Ebrahimi A. Relationship  between bladder evacuation methods and urinary infection in spinal cord injuries in Kerman. From Science to Practice Congress: 20 universally of Medical School, Kerman University of Medical Sciences, October 31-November 2, 1998, Kerman, Iran.

15.Janghorbani M. The incidence and factors influencing incidence of low birth weight in Kerman. From Science to Practice Congress: 20 universally of Medical School, Kerman University of Medical Sciences, October 31-November 2, 1998, Kerman, Iran.

16.Janghorbani M. An epidemiological study of tuberculosis in children under 10 years of age. Tuberculosis Symposium November 17-21,1984, Tabriz, Iran.

17.Janghorbani M. Diagnosis & prognosis disclosure to adult dying cancer patients,: Part I. Physician attitude. The 10th Asian Pacific Cancer Conference August 20-23, Beijing China 1991.

18.Janghorbani M. Diagnosis & prognosis disclosure to adult cancer patients,: Part 2. Patients attitude. 13th Asian Pacific Cancer Conference August 20-23, Penang Malaysia 1996.

19.Janghorbani M, Hedley AJ, Zhianpour M, Jones RB Gilmur WH. Blood pressure components as predictor of ischaemic heart disease mortality  in  west  of  Scotland. 2nd  Iranian  hypertension  Seminar, November 28-30, 1988, Yazd, Iran.

20.15th International Cancer Congress August 16-22, 1990 Hamburg,Germany.

21.Janghorbani M, Jones RB, Hedley AJ. Single casual blood glucose as a  predictor  of  later  development  of  diabetes  in  a  middle-aged population.    XIIth    Scientific    Meeting    of    the    International Epidemiological Association.   August 5-9, 1990, Los  Angeles, California USA.

22.Janghorbani M, Jones RB, Hedley AJ. Single casual blood glucose as a  predictor  of  later  development  of  diabetes  in  a  middle-aged population. First Iranian Diabetes Congress November 16-18 , 1993, Yazd, Iran.

23.Janghorbani  M.  Principles  of  epidemiology. 10th  International  Congers of Geographic Medicine of Shiraz University of Medical Sciences & 6th Iranian Congress of Infectious and Tropical Disease. November 10-13, 1997, Shiraz, Iran.

24.Janghorbani M, Jones RB, Allison S. Incidence of and risk indicators for cataract among diabetes clinic attenders. International Congress on Preventive Ophthalmology. July 25-27, 1998, Amsterdam, Netherlands.

25.Janghorbani M, Shafiee-Bafti M. Effects of smoking habits of family adults on respiratory health of children in Kerman, Iran.5th IEA Eastern Mediterranean Regional Scientific Meeting. Bahrain: October 23-25, 2000.

26.Janghorbani M. Effect of smoking habits of father on health of children and wife. First National Congress on Preventive Medicine and Public Health. Kermanshah, Iran, November 22-23, 2000.

27.Janghorbani M. Prevalence of hypertension among teachers, Kerman, Iran. The 5th International Conference on Preventive Cardiology. May 27-31, 2001 Osaka, Japan.

28.Daneshvar - Farzanegan P, Baghaiee M, Janghorbani M, Karimi J. Prevalence  of  cutaneous  leishmaniasis  health  center  attenders  in Borkhar and Mimeh. The 10th Iranian Congress on Infectious Disease and Tropical Medicine 5-9 Jan. 2002. Iran University of Medical sciences,Tehran.

29.Janghorbani M, Shafiee-Bafti M. Effects of smoking habits of family adults on respiratory health of children in Kerman, Iran.11th  Conference of the International Society for Environmental Epidemiology (ISSE_and 9t Conference of the International Society of Exposure Analysis (ISEA), Sept. 5-8, 1999, Athens, Greece.

30.Daneshvar - Farzanegan P, Baghaiee M, Janghorbani M, Karimi J, Mtovali-Emami M. Distribution of cutaneous leishmaniasis in Borkhar and Mimeh. 2nd Congress on Preventive Medicine and Public Health. Kermanshah, Iran, November 6-8, 2001.

31.Janghorbani  M,  Garak-Yaraghi  M,  Sherkat  R,  Izadi  S,  Rafiee-Moghadam B. Anti-cardiolipin antibodies and risk of coronary heart disease. The 3rd Mediterranean Congress on Heart Health, Cardiology Update 2002, and  WHO  Workshop  on  “Secondary  Prevention  of  Myocardial Infarction”. Giza, Egypt 10-13 April, 2002.

32.Janghorbani M, Lam TH, Fan S, Fielding R. Voluntary HIV antibody testing amongst youth in Hong Kong. International  Conference, Impact  of  Global  Issues  on  Women and Children, 16-21 February 2003, Bangkok, Thailand.

33.Janghorbani M, Lam TH, Hedley AJ, Ho SY, McGhee SM, Chan B. Public opinion on smoking ban in restaurant and predicted effect on patronage in Hong Kong. 12 World Conference on Tobacco or Health, 3-8 August 2003, Helsinki, Finland.

34.Janghorbani M. International Training program in occupational safety and  health  and  development.  The  Swedish  National  Institute  for working life. Swedish International Development Cooperation Agency (SIDA).  First course period. Stockholm Sweden Sept 24- Oct. 26, 2001.

35.Janghorbani M. International Training program in occupational safety and  health  and  development.  The  Swedish  National  Institute  for Working Life. Swedish International Development Cooperation Agency (SIDA).  Second course period. Captown, South Africa  May 24- 30,2002.

36.Janghorbani M. International Training program in occupational safety and health and development  . The Swedish  National Institute for    Working Life. Swedish International Development Cooperation Agency (SIDA). Third course period. Casablanca, Morroco, Sept 10- 20, 2003.

37.Janghorbani  M.  Asian  AMEA  Inaugural  Symposium.  Medical Education in the 21st Century. June 21 & 22, 2001, Hong Kong, China.

38.Janghorbani M, Lam TH, Fan S, Fielding R. Voluntary HIV antibody testing amongst youth in Hong Kong. IEA South East Asia Congress of Epidemiology, 24-27 February 2002, Jhansi (U.P.) India.

39. Janghorbani  M,  Sharifirad  GR.  Epidemiology  of  completed  and attempted suicide in Ilam, Iran (1992-2002). Third Conference on Epidemiological  Longitudinal  Studies  in  Europ,  CELSE-3, 22-25 September 2004, Bristol UK.

40. Janghorbani M. Epidemiology of colorectal cancer. The 3rd Regional Conference  of  Asian  pacific  Organization  for  Cancer  Prevention (APOCP): GI Cancer Control. 25-27 April 2005 , Zibakenar, Rasht, Iran.

41.Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in Isfahan,  Iran:  Incidence  and  risk  factors.  The  XVIIth  IEA  World Congress   of   Epidemiology.   Epidemiology   &   Equity   in   Health: Methodological Challenges & Strategies for 21th Century. Imperial Queen’s Park Hotel. 21-25 August 2005, Bangkog, Thailand.  


42.  Janghorbani M, Jones RB, Nerlder R. Neighbourhood deprivation and excess coronary heart disease mortality and hospital admission in Plymouth,  UK: an ecological study. The XVIIth IEA World Congress of Epidemiology. Epidemiology & Equity in Health: Methodological Challenges & Strategies for 21th Century. Imperial Queen’s Park Hotel. 21-25 August 2005, Bangkog, Thailand.

43.Janghorbani M, Rezvanian  H, Kachooei  A, Ghorbani A, Chitsaz  A, Izadi, F, Amini M. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors. The first world congress on  Controversies in Obesity, Diabetes and Hypertension (CODHy) October 25-29, 2006, Estrel Hotel, Berlin, Germany.

44.Janghorbani M, Taghdisi MT, Vingard E . Public opinion on smoking ban in restaurant  in Isfahan, Iran. !3th Word Conference on tobacco OR Health. Building capacity for a tobacco-free world. July 12-15 2006,  Washington DC, USA.

45.Janghorbani   M.   Epidemiology  of  multiple  sclerosis.  The 3rd Internation Congress on Multiple Sclerosis. November 16-17, 2006, Isfahan, Iran.

46.Shaygannejad  V,  Janghorbani  M,  Etemadifar  M,  Maghzi AH. Comparison of interferon beta products and azathioprine in treatment of  relapsing remitting multiple sclerosis. The 3rd Internation Congress on Multiple Sclerosis. November 16-17, 2006, Isfahan, Iran.

47. Janghorbani M, Amini M, Willett WC, Gouya MM,  Delavari AR, Alikhani  S,  Mahdavi  AR.  FIRST  NATIONWIDE  SURVEY  OF            PREVALENCE   OF   OVERWEIGHT,   UNDERWEIGHT,   AND ABDOMINAL  OBESITY  IN  IRANIAN  ADULTS.  !5th  European          Congress on Obesity. April 22-25, 2007, Budapest, Hungary.

48.Janghorbani  M,  Amini  M.  Prevalence  of  diabetes  and  impaired glucose regulation in first degree relatives of patients with type 2 diabetes. 1st  National Congress of Endocrine and Metabolism Updates. October 31 to November 1, 2007, Isfahan, Iran.

49.Janghorbani M, Amini M, Willett WC, Gouya MM,  Delavari AR, Alikhani  S,  Mahdavi  AR.  FIRST  NATIONWIDE  SURVEY  OF PREVALENCE   OF   OVERWEIGHT,   UNDERWEIGHT,   AND  ABDOMINAL  OBESITY  IN  IRANIAN  ADULTS.  1st    National Congress  of  Endocrine  and  Metabolism  Updates.  October 31  to November 1, 2007, Isfahan, Iran.

50.Janghorbani  M,  Adibi  A,  Shayganfar  S,  Amini  M.  first  degree relatives of patients with type 2 diabetes mellitus  and risk of non-alcoholic fatty liver diseae. 1st  National Congress of Endocrine and Metabolism  Updates. October 31 to November 1, 2007, Isfahan, Iran.

51.Shaygannejad, V; Janghorbani, M; Ashtari, F, et al. Comparative frequency of word finding impairment in relapsing-remitting multiple sclerosis patients, and a control group Conference Information: 12th Congress of the  European-Federation-of-Neurological-Societies, Date: AUG 23-26, 2008 Madrid SPAIN  Source: EUROPEAN JOURNAL OF NEUROLOGY   Volume: 15 Pages: 147-147   Published: 2008.

52. ):  Shayganmejad,  V;  Janghorbani,  M;  Ashtari,  F,  et  al.  Does rivastigmine improve memory  in multiple sclerosis? Conference Information: 23rd Congress of the European-Committee-for-Treatment-and-Research- in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Date: OCT 11-14, 2007 Prague CZECH REPUBLIC Source: MULTIPLE SCLEROSIS   Volume: 13   Pages: S127-S127 Published: 2007.

53. Hedley, AJ; McGhee, SM; Repace, J, Wong TW, Yu MYS, Chan AYW, Lam TH, Lo PCK, Tsang M, Wong LC, Chan ALN, Ng ESL, Janghorbani M. .Analysis of dose, exposure, and risk for 104 Hong Kong catering workers exposed to secondhand smoke (SHS) at work only Source: EPIDEMIOLOGY   Volume: 13   Issue: 4   Pages: S231-S232 Published: JUL 2002 Meeting Abstract: 848

54.Janghorbani,   M.   Critical   appraisal   of   systematic   reviews Conference Information: 4th Regional Congress on Medical Journals in Eastern Mediterranean Region November 5-7, 2008 Bahrain

55.Title: Effects of glucosamine sulfate on multiple sclerosis progression: a randomized, placebo-controlled trial Author(s):   Shaygannejad, V;  Ashtari,  F;  Janghorbani,   M Conference Information: 13th Annnual Meeting of  the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of  the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Date: SEP 17-20, 2008 Montreal  CANADA Source: MULTIPLE SCLEROSIS   Volume: 14   Pages: S178-S178 Published: 2008.

56.Janghorbani, M, Amini M. Comparison of metabolic syndrome with glucose measurement for prediction of type 2 diabetes: the isfahan Diabetes Prevention Study.Conference Information: 2nd Iranian Congress of Endocrine and Metabolism Updates April 22-24, 2009 Isfahan, Iran

57.Janghorbani, M, Amini M. Effect of gender and height on the oral glucose   tolerance   test:   the   isfahan   Diabetes   Prevention   Study. Conference Information: 2nd  Iranian Congress of Endocrine and Metabolism Updates April 22-24, 2009 Isfahan, Iran

58.Janghorbani,  M,  Aminorroaya,  A,  Amini  M.  Prevalence of  hypothyroidism in iodine replete area in Iran. Conference Information: 2nd  Iranian Congress of Endocrine and Metabolism Updates April 22-24, 2009  Isfahan, Iran

59.Janghorbani, M, Amini M. Pattern and predictors of long-term weight change in patients with type          2 diabetes mellitus. Conference Information: 2nd  Iranian Congress of Endocrine and Metabolism Updates April 22-24, 2009 Isfahan, Iran

60. Roya Sherkat, M. Garak-Yaraghi, M. Janghorbani, Shiva Izadi, B. Rafiee-Moghadam and J. Hasheminia. Anti-Cardioliphin Antibodies and Risk of Coronary Heart Disease. 9th Annual Meeting, Federation of Clinical Immunology Societies 2009. Clinical Immunology. Volume 131, Supplement 1, 2009, Page S147.

61. M. Janghorbani, M. Amini, M. Gouya, A. Delavari, S. Alikhani, A. Mahdavi. NATIONWIDE SURVEY OF PREVALENCE AND RISKFACTORS  OF  PREHYPERTENSION  AND  HYPERTENSION  IN IRANIAN ADULTS. 77th Congress of the European Atherosclerosis Society,   April           26-29,  2008,   Istanbul,   Turkey. AtherosclerosisSupplements, Volume 9, Issue 1, May 2008, Page 213.

62. Mohsen  Janghorbani,  Atoosa  Adibi  Sanaz  Shayganfar,  Masoud Amini.  Nondiabetic first  degree relatives of patients with Type 2 diabetes and risk of non alcoholic fatty liver disease. Diabetes Research and Clinical Practice, Volume 79, Supplement 1, February 2008, Page S102.

63. Janghorbani  M,  Amini  M.  COMPARISON  OF  METABOLIC SYNDROME    WITH    GLUCOSE    MEASUREMENT    FOR PREDICTION OF TYPE 2 DIABETES: THE ISFAHAN DIABETES PREVENTION  STUDY.  Controversies  to  Consensus  in  Diabetes, Obesity and Hypertension (CODHy) October 30 - November 2, 2008, Barcelona, Spain.

64.Mohsen Janghorbani. Pattens and predictors of long-term weight change in patients with type 2 diabetes mellitus. Annals of Nutrition and Metabolism 2009; 55 (Suppl 1): 349. 19th International Congress of Nurition.  October 4-9, 2009, Bangkok, Thailand.

65. Sheikhi A, Janghorbani M, Soleimani B. Relation between obesity and depression using structural equation modeling. Stochastic Modeling Techniques and Data Analysis International Conference (SMTDA2010), 8-11 June  2010, Chania Crete Greece.

66. Janghorbani M, Amini M. Long-term impact of weight change on blood pressure, lipids and metabolic control among patients with type 2 diabetes. Longitudinal and Life Course Studies 2010 1 (3) Supplement :84. The 5th conference of Epidemiological Longitudinal Studies in Europe (CELSE2010)  13-15 October 2010, Paphos Cyprus.

67. Janghorbani M. Diabetes and cancer. 1st International and 3rd Iranian Congress of Endocrine and Metabolism Updates. 30 Nov. - 3 Dec. 2010. Isfahan University of Medical sciences, Iran.

68. Janghorbani M. Principles of screening. 1st Advance screening in medicine. 24 may -26 May 2011. Mashad, Azad Islamic University.

69. Janghorbani M. Incidence of Type 2 Diabetes by HbA1c and OGTT: The  Isfahan  Diabetes  Prevention  Study.  IEA  World  Congress  of Epidemiology 7 - 11 August 2011 Edinburgh International Conference Centre, Scotland, UK. 25


70.Janghorbani  M.  Weight  Change  and  Blood  Pressure,  Lipids  and Glycemic Control among Patients with Type 2 Diabetes. IEA World Congress of Epidemiology 7 - 11 August 2011. Edinburgh International  Conference Centre, Scotland , UK.

71. Janghorbani M. SYSTEMATIC REVIEW AND META-ANALYSIS OF INSULIN THERAPY AND RISK OF CANCE. 7th World Congress of Prevention of Diabetes and Its Complications 11-14 November 2012.  Madrid, Spain.

72. Janghorbani M., Mansourian M, Hosseini E. Systematic review and meta-analysis of age at menarche and risk of type 2 diabetes. 2014 Seoul International Congress of Endocrinology and Metabolism 15-18 May 2014, Seoul,  South Korea.

 

 

B. Translator of Following Books:

 

1.  Hulley SB, Cummings S (ed.), Janghorbani M, Sadeghi-Hassanabadi A (translator).Designing  Clinical Research. Jehad Daneshgahi Publications Tehran 1995.

2.Beaglehole R, Bonita R, Kjellstrom T (eds.), Janghorbani M, Zhianpour M (translator).Basic Epidemiology. Ministry of Health and Medical Education Publication, Tehran 1992.

3. Fletcher RH, Fletcher SW, Wagner EH (eds.), Janghorbani M, SadeghiHassanabadi A (translator). Clinical Epidemiology: The essentials. 1st edition Shiraz University of Medical Sciences Publication Shiraz, 1995.

4. Freedman GD (ed.), Janghorbani M, Sadeghi-Hassanabadi A (translator). Primer of Epidemiology. Jehad Daneshgahi Publications Tehran 1993.

5. Mausner S, Kramer (ed.). Janghorbani M (translator). Mausner & Bahn Epidemiology An Introductory Text. Kerman Cultural Services Publications 1st edition Kerman 1994.

6. Mausner S, Kramer (ed.). Janghorbani M (translator). Mausner & Bahn Epidemiology An Introductory Text. Kerman Cultural Services Publications 2nd edition Kerman 1994.

7. Austin MG (Eds.) Janghorbani M, Zhianpour M (translator). Young’s Learning Medical Terminology.  1st ed., Jehad Daneshgahi Publications Tehran 1990.

8. Austin MG (eds.), Janghorbani M, Zhianpour M (translator). Young’s Learning Medical Terminology.  2nd ed., Jehad Daneshgahi Publications Tehran 1996.

9. Fletcher RH, Fletcher SW, Wagner EH (eds.), Janghorbani M, Sadeghi- Hassanabadi A (translator). Clinical Epidemiology: The essentials.2nd edition, Shiraz University of Medical Sciences Publication Shiraz, 1999.

10. Abramson JH (Eds.) Sadeghi-Hassanabadi A Janghorbani M (translator) Survey Methods in Community Medicine:Epidemiological studies, programme evaluation, clinical trials. 4th edition. Shiraz University of Medical  Sciences Publication Shiraz, 2000.


11.Greenberg RS, Daniels SR, Flanders WD, Eley JW, Borin JR. Medical Epidemiology. Isfahan University of Medical Sciences Press, Isfahan, 2000.

12. Last MJ. A Dictionary of Epidemiology. Isfahan University of Medical Sciences Press, Isfahan, 2001.

13. Giesecke J. Modern infectious disease epidemiology. Office of Preventive and Control of Disease. Ministry of Health, Treatment and Medical Education Tehran 2001.

14. Mausner S, Kramer (ed.). Janghorbani M (translator). Mausner & Bahn Epidemiology An Introductory Text. Kerman Cultural Services Publications 3rd edition Kerman 2002.

15. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman T (ed.), Janghorbani M (translator). Designing  Clinical Research. 2nd edition, Isfahan University of Medical Sciences Press, Isfahan, 2003 .

16. Mausner S, Kramer (ed.). Janghorbani M (translator). Mausner & Bahn Epidemiology An Introductory Text. Kerman Cultural Services Publications 4th edition Kerman 2005.

17. Mausner S, Kramer (ed.). Janghorbani M (translator). Mausner & Bahn Epidemiology An Introductory Text. Kerman Cultural Services Publications 4th edition Kerman 2005.

18. Mausner S, Kramer (ed.). Janghorbani M (translator). Mausner & Bahn Epidemiology. An Introductory Text. Kerman Cultural Services Publications 5th edition Kerman 2008.

 

 

 

 

Editor of Following Books:

1.  Azizi F, Janghorbani M and Hatami H (eds.). Epidemiology and Control of  Common Diseases in Iran. Nashreh Eshtiagh,Tehran 2001.

2.  Janghorbani M (contributor): Last MJ. A dictionary of Epidemiology .4th ed. Oxford University Press. 2001.

3.  Janghorbani M. Textbook of Public Health. 1st revision.

4.  Azizi F, Janghorbani M and Hatami H (eds.). Epidemiology and Control of Common Diseases in Iran. Khosravi,Tehran 2010.

5.  Janghorbani M. Textbook of Public Health. 3rd revision, Ketab Arjomand, 2013.

 

 

 

Member of Board of Consultants of  Following Journals:

1. Journal of Islamic Republic of Iran

2. Journal of Kerman University of Medical Sciences, Iran.

3. Journal of Babol University of Medical Sciences, Iran.

6.  Journal of Ghazvin University of Medical Sciences, Iran.

7.  Journal of Research in Medical Sciences, Isfahan, Iran

 

Member of Editorial Board of Following Journals:

1. Journal of Research in Medical Sciences, Isfahan, Iran

2. Journal of Babol University of Medical Sciences, Iran

3. Dental Journal of Isfahan University of Medical Sciences.

4. Editor of Journal of Research in Medical Sciences, Isfahan, Iran

 

 

Member of the Following Societies and Meetings:

1. International Epidemiological Association

2. The Royal Institute of Public Health & Hygiene and the Society of Public Health

3. Iranian Society of Family Planning

4. The International Association for Study of Lung Cancer (ex-member)

5. American Public Health Association (ex-member)

6. The Global Environmental Epidemiology Network

7. Member of the Regional Organising Committee of the 4th International Epidemiological Association/Eastern Mediterranean Region Scientific meeting, Tunis, Tunisia 1998.

8. Member of the Organising Committee of the From Science to Practice Congress, Kerman, Iran 1998.

9. Member of the Regional Organising Committee of the 5th International Epidemiological Association/Eastern Mediterranean Region Scientific meeting, Menama, Bahrain, 2000.

10. Member of American Diabetes Association (ex-member).

11. Member of the Scientific Committee of the First National Congress on Preventive Medicine and Public Health. Kermanshah, Iran, November 22-23, 2000.

12. Member of the board of Iranian Epidemiological Association.

13. Member of the Scientific Committee of the Second National Congress on Preventive Medicine and Public Health. Kermanshah, Iran, November 6-9, 2001.

14.  Member of the Regional Organising Committee and Scientific committee of the 6th International Epidemiological Association/Eastern Mediterranean Region Scientific meeting, Ahwaz, Iran December 9-11, 2003.